"Navigating the Modern News Zoo so you don't have to."
Tuesday, April 15, 2025
A new drug delivery system may help patients with a rare eye cancer
A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to their liver. This disease, known as metastatic uveal melanoma, is traditionally very hard to treat and usually has poor outcomes.
š Full Story
Boat Cruise Turned Into a Full-Blown Fight in Florida Waters!
- Espresso 15 Pro review: Just a really nice (though pricey) portable monitor - Sam Rutherford
- UK on alert after H5N1 bird flu spills over to sheep in world-first - Beth Mole
- How The Star Wars Sequels Doomed Disney+ - Chris Snellgrove
- How Much Down Payment Is Required for a House?
- YRKKH Written Update 11 August 2024: Abhira Refuses to Marry Arman as Ruhiās Plan Unfolds! - Aaradhana Chaurasia
- Blue Originās all-female crew, including Katy Perry, successfully launched - Lauren Forristal
2000 vs 30000 INR Smart Glasses!
- Poolhouse raises $34M for gamified pool from the creators of Topgolf - Dean Takahashi
- Scalable technique for single-cell sequencing enhances drug screening research
- Conifer locks down $20M seed round for its ādrop-inā electric hub motor - Sean O'Kane
- This AI already writes 20% of Salesforceās code. Hereās why developers arenāt worried - Michael NuƱez
- Does a Humidifier Help With Allergies? - Lindsay Curtis
- Understanding and Managing Duck-Footedness: A Comprehensive Guide - Mark Gurarie
